Citation only
via Europe PMC
DHA as a systems regulator of neuroinflammation: A narrative review integrating membrane organization, immunometabolism, and inflammatory resolution.
Aguila MB, Mandarim-de-Lacerda CA.
Histology and histopathology · 2026
Abstract
Neuroinflammation is a central feature of brain aging and a major driver of neurodegenerative and neuropsychiatric disorders. Conventional anti-inflammatory strategies have produced inconsistent clinical outcomes, reflecting the biological complexity of chronic neuroinflammation and the limited capacity of single-target interventions to modulate interconnected pathogenic pathways. This narrative review synthesizes evidence from mechanistic studies, clinical trials, and meta-analyses identified through structured searches of PubMed, Scopus, and Web of Science. Docosahexaenoic acid (DHA), the predominant omega-3 fatty acid in the brain, modulates neuroinflammatory processes through coordinated effects on membrane organization, intracellular signaling, mitochondrial function, and inflammatory resolution. DHA remodeling of membrane phospholipids alters lipid raft-dependent signaling, attenuates activation of nuclear factor kappa B (NF-κB) and the NLR family pyrin domain-containing 3 (NLRP3) inflammasome, enhances mitochondrial bioenergetics and redox homeostasis, and promotes the generation of specialized pro-resolving mediators. Aging-associated processes, including microglial priming, metabolic dysfunction, impaired lipid transport, blood-brain barrier (BBB) dysfunction, and altered glial responsiveness, further reshape DHA availability and therapeutic responsiveness. These factors contribute to heterogeneous clinical outcomes, as intervention studies often fail to account for baseline omega-3 status, genetic variability, metabolic phenotype, formulation-dependent bioavailability, disease stage, and exposure duration. Emerging lipidomic and biomarker-guided approaches may better characterize biological heterogeneity in DHA intervention studies. We propose a systems-level model in which DHA integrates structural, bioenergetic, and immune-resolution domains governing neuroinflammatory homeostasis, adaptive resilience, and vulnerability to neurodegeneration during aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.14670/hh-25-155
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
MB, A., & CA., M. (2026). DHA as a systems regulator of neuroinflammation: A narrative review integrating membrane organization, immunometabolism, and inflammatory resolution. <em>Histology and histopathology</em>. https://doi.org/10.14670/hh-25-155
Vancouver
MB A, CA. M. DHA as a systems regulator of neuroinflammation: A narrative review integrating membrane organization, immunometabolism, and inflammatory resolution. Histology and histopathology. 2026. doi:10.14670/hh-25-155.
BibTeX
@article{aguila2026DHAasa,
title = {DHA as a systems regulator of neuroinflammation: A narrative review integrating membrane organization, immunometabolism, and inflammatory resolution.},
author = {Aguila MB and Mandarim-de-Lacerda CA.},
journal = {Histology and histopathology},
year = {2026},
doi = {10.14670/hh-25-155},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nutrients 2026
Open access · CC-BY
Inflammaging and Sarcopenia as Interconnected Hallmarks of Aging: Integrative Roles of Bioactive Compounds and Lifestyle Interventions
Nutrients 2026
Citation only
Inflammaging and Sarcopenia as Interconnected Hallmarks of Aging: Integrative Roles of Bioactive Compounds and Lifestyle Interventions.
Nutrients 2026
Open access · CC-BY
Food-Derived Omega-3 Fatty Acids and Cognitive Aging: Integrating Nutritional Neuroscience and Geroscience
Nutrients 2026
Open access · OA
Food-Derived Omega-3 Fatty Acids and Cognitive Aging: Integrating Nutritional Neuroscience and Geroscience.
Aging cell 2026
Open access · OA
Magnesium as a Bioenergetic Checkpoint Linking Mitochondrial Function, Metabolic Disease, and Aging.
Pharmaceuticals (Basel, Switzerland) 2026
Citation only